Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q86Y56
UPID:
DAAF5_HUMAN
Alternative names:
HEAT repeat-containing protein 2
Alternative UPACC:
Q86Y56; Q69YL1; Q96FI9; Q9NX75
Background:
Dynein axonemal assembly factor 5, also known as HEAT repeat-containing protein 2, plays a pivotal role in the assembly of dynein arms essential for motile cilia function. This cytoplasmic protein ensures the delivery of dynein machinery, facilitating cilium motility by attaching to the axoneme's outer doublet A microtubule.
Therapeutic significance:
Given its crucial role in cilia motility, Dynein axonemal assembly factor 5 is directly implicated in Ciliary dyskinesia, primary, 18, a condition marked by motile cilia abnormalities leading to severe respiratory infections and reduced fertility. Understanding the role of this protein could open doors to potential therapeutic strategies for treating ciliary dysfunctions.